176 related articles for article (PubMed ID: 8299225)
1. Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1 (CR1, CD35) on human erythrocytes.
Gibson NC; Waxman FJ
Clin Immunol Immunopathol; 1994 Feb; 70(2):104-13. PubMed ID: 8299225
[TBL] [Abstract][Full Text] [Related]
2. Isotypic and clonal variations in the interactions between model monoclonal immune complexes and the human erythrocyte CR1 receptor.
Yokoyama I; Waxman F
Mol Immunol; 1992; 29(7-8):935-47. PubMed ID: 1386141
[TBL] [Abstract][Full Text] [Related]
3. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.
Nielsen CH; Matthiesen SH; Lyng I; Leslie RG
Immunology; 1997 Jan; 90(1):129-37. PubMed ID: 9038723
[TBL] [Abstract][Full Text] [Related]
4. Differential susceptibility of immune complexes to release from the erythrocyte CR1 receptor by factor I.
Yokoyama I; Waxman F
Mol Immunol; 1994 Feb; 31(3):227-40. PubMed ID: 8114768
[TBL] [Abstract][Full Text] [Related]
5. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
Schifferli JA; Ng YC; Paccaud JP; Walport MJ
Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
[TBL] [Abstract][Full Text] [Related]
6. A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes.
Oudin S; Libyh MT; Goossens D; Dervillez X; Philbert F; Réveil B; Bougy F; Tabary T; Rouger P; Klatzmann D; Cohen JH
J Immunol; 2000 Feb; 164(3):1505-13. PubMed ID: 10640768
[TBL] [Abstract][Full Text] [Related]
7. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
8. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms.
Cohen JH; Atkinson JP; Klickstein LB; Oudin S; Subramanian VB; Moulds JM
Mol Immunol; 1999; 36(13-14):819-25. PubMed ID: 10698335
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).
Reilly BD; Mold C
Clin Exp Immunol; 1997 Nov; 110(2):310-6. PubMed ID: 9367418
[TBL] [Abstract][Full Text] [Related]
10. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
Craig ML; Waitumbi JN; Taylor RP
J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
[TBL] [Abstract][Full Text] [Related]
11. Immune complexes bind preferentially to specific subpopulations of human erythrocytes.
Cosio FG; Shen XP; Hebert LA
Clin Immunol Immunopathol; 1990 Jun; 55(3):337-54. PubMed ID: 2140304
[TBL] [Abstract][Full Text] [Related]
12. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
[TBL] [Abstract][Full Text] [Related]
13. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
Paccaud JP; Carpentier JL; Schifferli JA
Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
[TBL] [Abstract][Full Text] [Related]
14. Influence of processing by erythrocyte C3b/C4b receptors (CR1) on binding of immune complexes to Raji cells and polymorphonuclear granulocytes.
Rasmussen JM; Jepsen HH; Svehag SE
Scand J Immunol; 1987 Oct; 26(4):437-44. PubMed ID: 2961050
[TBL] [Abstract][Full Text] [Related]
15. Zinc ions inhibit factor I-mediated release of CR1-bound immune complexes and degradation of cell-bound complement factors C3b and C4b.
Jepsen HH; Teisner B; Svehag SE
Scand J Immunol; 1990 Apr; 31(4):397-403. PubMed ID: 2139734
[TBL] [Abstract][Full Text] [Related]
16. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.
Kisserli A; Schneider N; Audonnet S; Tabary T; Goury A; Cousson J; Mahmoudi R; Bani-Sadr F; Kanagaratnam L; Jolly D; Cohen JH
Immunobiology; 2021 May; 226(3):152093. PubMed ID: 34022670
[TBL] [Abstract][Full Text] [Related]
17. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
Taylor RP; Pocanic F; Reist C; Wright EL
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
[TBL] [Abstract][Full Text] [Related]
18. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
19. How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?
Nardin A; Lindorfer MA; Taylor RP
Mol Immunol; 1999; 36(13-14):827-35. PubMed ID: 10698336
[TBL] [Abstract][Full Text] [Related]
20. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model.
Taylor RP; Ferguson PJ; Martin EN; Cooke J; Greene KL; Grinspun K; Guttman M; Kuhn S
Clin Immunol Immunopathol; 1997 Jan; 82(1):49-59. PubMed ID: 9000042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
